The latest version of the Canadian ADHD medication chart is available in a Canada-wide [PDF here] or Quebec [PDF here] adaption (latest update: April 2019). Physicians may find the chart useful when discussing medication with patients and their families.

The charts (available in English or French) provide full colour illustrations of the medications available in Canada and list recommended doses. They show the dose titration per product monograph and CADDRA guidelines. The charts were first developed by the continuing medical education team at Laval University in Quebec City in collaboration with the organizational committee for the conference on the pharmacological treatments of ADHD in April 2007.  The charts are updated with any changes and the new version provided online for download.

Thanks to the Laval CME team and Réseau TDAH Québec, these charts are in the public domain and available for everyone to access through the Laval University CME website, the website of Dr Annick Vincent in Quebec and now also through the CADDRA website. Laminated versions of the medication charts are included with every copy of the new Canadian ADHD Practice Guidelines,  which are provided without cost to CADDRA members or can be ordered from the CADDRA office by non-members.